Qing Zhang

@DanaFarber @DrChoueiri Congratulations, Toni! Well deserved!

Congratulations to @DrChoueiri, director of the Lank Center for Genitourinary Oncology, who was recently elected to one of the nation’s most prestigious medical organizations, the Association of American Physicians. Choueiri joins 47 other AAP members affiliated with Dana-Farber. Read more: bit.ly/499WOv0

@IamLinghua @UTMDAnderson Big congratulations, Linghua!

Deeply grateful to Peggy and Carl Sewell for their visionary $10M gift and their trust in our mission. With this transformative support, we are building a new scientific frontier at @UTMDAnderson to decode the "language" of cancer. mdanderson.org/newsroom/ut-md…

Our vision for the cardio-immunology program at UCSF! We will be hiring new post-doctoral fellows and physicians in this space. Stay tuned for more information! @UCSFCardiology @immunox

@UTSW_Pathology Thank you!!

A must read 👉🏻 doi.org/10.1172/JCI201…

📣 Publication Alert @jclinicalinvest by @QingZhangLab @ChenghengLiao @Ram_Mani_PhD from @UTSW_Pathology A genome-wide CRISPR screen reveals a cytokine-enhancer circuit sustaining HIF-2a in renal cancer and point JAK-STAT3 targeting as a strategy to overcome resistance 👉🏻

@yu_jindan @jdlicht Congratulations, Jindan! Well deserved!!

So glad to become a member of AAP. With my nominator and sponsor @jdlicht

@EsraAkbay_ Thank you!!

@QingZhangLab Can't keep up! one paper/week! @QingZhangLab Congratulations

Thrilled to share our latest publication on selected degradation of TBK1 in blocking tumor progression in RCC (as well as in PDAC). sciencedirect.com/science/articl…

@ChenghengLiao @UNCPharmacy @UNC_Lineberger @NIH @CPRITTexas @AmerUrological @UTSW_Pathology @utswcancer Here is the free access link: authors.elsevier.com/a/1muqi8jWWK2z…

Led by @ChenghengLiao and collaborative efforts with Lindsey James @UNCPharmacy @UNC_Lineberger, supported by @NIH @CPRITTexas @AmerUrological @UTSW_Pathology @utswcancer

Editorial team from @CellChemBiol is great to work with and our special thanks to our reviewers making our paper better!

@DrChoueiri @OncJournal @DanaFarber_GU @DanaFarberNews @DanaFarber @harvardmed @Harvard @brian_rini @motzermd very important study! Congratulations to the dream team @DrChoueiri @CardioOncology !

Our work out of #JavelinRenal101 in @OncJournal remains relevant and brings wealth of info to designing next clinical trials for VEGF/IO (and even new drugs): A notable proportion of patients have high baseline and on-therapy cardiac. However, NO association between elevation in cardiac biomarkers and incidence of major adverse cardiac events ! cc: @CardioOncology academic.oup.com/oncolo/advance…

@QinYan1 @UTSWMedCenter @kaelin_lab @yalepathology @YaleMed @Yale big congratulations, Qin. Well deserved!!

I am really honored for this. This would not be possible without the hard work of my trainees, guidance by mentors including Joan and Ron Conaway @UTSWMedCenter , @kaelin_lab, David Stern, and Jeff Sklar, and support of my colleagues @yalepathology @YaleMed @Yale, and my family.

@Lab_AKundu Thanks!!

@QingZhangLab Congratulations

JCI - Genome-wide CRISPR screen identifies a cytokine–enhancer circuit driving HIF-2α activation in renal cancer jci.org/articles/view/…

@EsraAkbay_ Thank you, Neighbor!

@QingZhangLab Congratulations @QingZhangLab

@LilyHuangLab Thank you, Lily!

@QingZhangLab Very interesting! Congrats!

@ishahjain Thanks!!

@QingZhangLab Congrats!!! Can’t wait to read :)

@WilliamKimMD Thank you!

Important VHL independent regulation of HIFα

Big Thanks for collaborations from many colleagues @jeremy_m_simon @ChenghengLiao @JBrugarolas @Ram_Mani_PhD and many more. Funding supported by DoD, @CPRITTexas and @theNCI @UTSWMedCenter @UTSW_Pathology @utswcancer

Glad to share our latest study on elucidating the HIF2a regulatory mechanism beyond the canonical VHL-HIF signaling. Our CRISPR screening identified SOCS3-JAK1-STAT signaling controlling HIF2a transcription.